NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/27/2021
Back to search
Official data from USPTO
UNITED THERAPEUTICS CORPORATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/27/2021
Trademark type
Combined
Nice classes
5
Filing date
12/16/1997
Registration date
05/15/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/27/2021
Last transaction
05/27/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/08/1997
First use in commerce
12/08/1997
Drawing code
3
Owner type
03
Owner location
Silver Spring, MD
Examiner
WILLIAMS KELLY L.
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
U. C. (pessoa física)
U. C. (pessoa física)
Representatives
Norm J. Rich Foley & Lardner LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of chronic conditionschronic heart diseasechronic lung diseasechronic vascular disease
Publications
History of USPTO decisions and trademark events.
29 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
05/27/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/27/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/27/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
02/22/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/15/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/06/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/06/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
05/05/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/12/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
05/09/2007
E815
TEAS SECTION 8 & 15 RECEIVED
05/09/2007
CFIT
CASE FILE IN TICRS
11/06/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
05/15/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/26/2001
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/07/2000
CNFR
FINAL REFUSAL MAILED
07/06/2000
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2000
CNRT
NON-FINAL ACTION MAILED
03/15/2000
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/01/2000
DPCC
DIVISIONAL PROCESSING COMPLETE
02/01/2000
IUAF
USE AMENDMENT FILED
07/23/1999
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
05/11/1999
PUBO
PUBLISHED FOR OPPOSITION
02/16/1999
NPUB
NOTICE OF PUBLICATION
01/15/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/05/1998
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/1998
CNRT
NON-FINAL ACTION MAILED
08/31/1998
DOCK
ASSIGNED TO EXAMINER
08/12/1998
Continuous trademark protection
Get notified about every new filing that threatens UNITED THERAPEUTICS CORPORATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.